Named on one round in the feed.
Since 2020-04-01
ROUNDS
1
joined, none as lead
ROUNDS JOINED · USD
$70M
across 1 round
CO-INVESTORS
5
named beside it
Named on one round in the feed.
Since 2020-04-01
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Aspen Neuroscience Aspen Neuroscience develops personalized regenerative therapies, specifically autologous iPSC-derived cell replacement therapies for Parkinson's disease. | Series A Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $70M | 2020-04-01 | [ PART ] |
No sector on record.